Sponsored Links
| Glycotope Enrolls First Patients In Phase I Trial For FSH-GEX™ |
 |
 |
 |
| Medical News - Fertility | |||
|
After the two monoclonal antibodies GT-MAB 2.5-GEX™ and CetuGEX™, the German biotech company Glycotope GmbH has recently received approvals to initiate clinical trials for its first glycooptimized non-antibody protein therapeutic FSH-GEX™... Read more: Fertility News From Medical News Today
|